CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $495,243 | -31.1% | 72,510 | +5.1% | 0.00% | – |
| Q2 2023 | $719,178 | +93.4% | 69,019 | +29.4% | 0.00% | – |
| Q1 2023 | $371,878 | +23.1% | 53,354 | +6.5% | 0.00% | – |
| Q4 2022 | $302,030 | -8.8% | 50,088 | +19.3% | 0.00% | – |
| Q3 2022 | $331,000 | -74.9% | 41,990 | -56.7% | 0.00% | -100.0% |
| Q2 2022 | $1,320,000 | -15.7% | 96,989 | +21.6% | 0.00% | 0.0% |
| Q1 2022 | $1,565,000 | -34.7% | 79,781 | +14.2% | 0.00% | 0.0% |
| Q4 2021 | $2,396,000 | -41.4% | 69,851 | -6.7% | 0.00% | -50.0% |
| Q3 2021 | $4,089,000 | -33.5% | 74,865 | -10.6% | 0.00% | -33.3% |
| Q2 2021 | $6,153,000 | -85.9% | 83,729 | -82.5% | 0.00% | -87.5% |
| Q1 2021 | $43,749,000 | +319.2% | 478,342 | +271.6% | 0.02% | +300.0% |
| Q4 2020 | $10,436,000 | +135.2% | 128,739 | +35.0% | 0.01% | +100.0% |
| Q3 2020 | $4,438,000 | – | 95,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |